BREAKING NEWS: someone wants to register 'Je suis Charlie' as a trade mark from ipkitten.blogspot.com Via @markmatter_ and @Loeffel_Abrar comes a piece of news that will be discussed more at length a bit later today. It concerns an application that has just been filed to register 'Je suis charlie' as ... Share via E–mail | Twitter | Facebook
Best vehicle for broadening patent protection from ocpatentlawyer.com Bottom line: Filing a continuing patent application is the best vehicle for broadening patent protection (i.e., patent’s claim), not reissue patent applications. In a broadening reissue patent application, the patent’s claims cannot ...
Share via E–mail | Twitter | Facebook
Lions, unicorns and the prospect of a licence from ipkitten.blogspot.com Among the various odds and ends that have crossed this Kat's line of vision of late is a link to a very official-looking web page entitled "Use of the Intellectual Property Office logo"
here ... Share via E–mail | Twitter | Facebook
Big, green and understated: the new Modern Law of Patents from ipkitten.blogspot.com Sometimes you put in a ton of effort, over and above the call of duty, and find yourself asking "is it all worth the hassle?" Authors of books published by LexisNexis may well be in ...
Share via E–mail | Twitter | Facebook
China’s IP journey: from ‘bad guys’ to ‘good guys’ to patent superpower from ipkitten.blogspot.com The purpose of this post is look at the development of the Chinese patent system and how China has made the transition from being a ‘pirate’ nation to a ‘protector’ of patent rights, acquiring a ...
Share via E–mail | Twitter | Facebook
IP Intensive: Experiencing the Heart of the Legal Technology Boom at CodeX from www.iposgoode.ca This fall semester I had the honour of attending CodeX: The Stanford Center for Legal Informatics as part of Osgoode’s Intellectual Property Law and Technology Intensive Program. CodeX’s broad mission is to design ...
Share via E–mail | Twitter | Facebook
Guest Post: 41 New Drugs Approved in '14 -- A Random Spike or a Growing Trend of Drug Innovation? from www.patentdocs.org By Cambria Alpha-Cobb* and Anthony D. Sabatelli** -- If innovation drives progress, then 2014 was the year of progress! During the past year the U.S. Food and Drug Administration approved 41 new drugs. That is ...
Share via E–mail | Twitter | Facebook
CARICOM, Trans-Pacific Partnership Agreement, IP Law And Policy: What Next? from www.ip-watch.org The year 2015 has dawned as usual with the fanfare of greater things to come. Caribbean projects are in the pipeline, along with activities to enhance competitiveness and many gallant efforts by well- meaning non-governmental ...
Share via E–mail | Twitter | Facebook
Panels Look At Proposed EU, French Trade Secret Legislations from www.ip-watch.org PARIS – French government officials and industry representatives gathered here recently to debate proposed new rules to protect trade secrets against unlawful acquisition, use and disclosure.
Share via E–mail | Twitter | Facebook
Defendant’s False Representation as to Use of Source Code Triggers Crime-Fraud Exception Requiring Production of Privileged Communications from docketreport.blogspot.com The court granted in part plaintiff's motion to compel the production of privileged documents under the crime-fraud exception to determine whether source code asserted as a defense to plaintiff's infringement claims was fabricated ...
Share via E–mail | Twitter | Facebook
Responsible Patent Licensing is Focus of NY Financial Conference from ipcloseup.wordpress.com Executives of top patent holders will participate in “NPE 2015: The Business of Responsible Licensing” to be held in NYC’s financial district on March 12. There are still some audiences that believe that NPE ...
Share via E–mail | Twitter | Facebook
Bard v. W.L. Gore: Revisiting Willful Infringement (Again) from patentlyo.com By Jason Rantanen Bard Peripheral Vascular, Inc. v. W.L. Gore & Associates, Inc. (Fed. Cir. 2015) 14-1114.Opinion.1-7-2015.1 Panel: Prost (author), Hughes (concurring), Newman (dissenting) Professor Tom Cotter has an excellent write-up of ...
Share via E–mail | Twitter | Facebook
Federal Appeals Court Directs FDA to Treat Reissue Patents as Separate and Distinct When Determining Eligibility for Pre-MMA 180-Day Exclusivity from www.iplawalert.com In Mylan Pharm., Inc. v. FDA, generic drug manufacturer Mylan Pharmaceuticals, Inc. (“Mylan”) challenged an FDA letter decision describing the agency’s treatment of original and reissue patents as “a single bundle of patent rights ...
Share via E–mail | Twitter | Facebook
Google Looks to Narrow both Copyrights and Patents through Supreme Court Action from patentlyo.com by Dennis Crouch Two pending Supreme Court now have higher profiles with the Supreme Court’s invitation to the Solicitor General to provide views of the administration. In both cases, the petitioners have set-up the ...
Share via E–mail | Twitter | Facebook